We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRC
26
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$92.3M 0.82%
812,813
+13,007
+2% +$1.46M
ROST icon
27
Ross Stores
ROST
$78.1B
$91.5M 0.81%
737,709
+120,827
+20% +$15.1M
LECO icon
28
Lincoln Electric
LECO
$14.1B
$89.5M 0.8%
679,586
+55,075
+9% +$7.05M
PNC icon
29
PNC Financial Services
PNC
$99.6B
$87.9M 0.78%
460,535
-1,940
-0.4% -$364K
SBUX icon
30
Starbucks
SBUX
$118B
$86.5M 0.77%
773,297
+1,778
+0.2% +$201K
JLL icon
31
Jones Lang LaSalle
JLL
$15.5B
$85.3M 0.76%
436,520
+5,736
+1% +$1.12M
PEP icon
32
PepsiCo
PEP
$191B
$84.8M 0.75%
572,514
-10,130
-2% -$1.48M
MANH icon
33
Manhattan Associates
MANH
$9.42B
$83.2M 0.74%
574,714
-31,258
-5% -$4.16M
CHE icon
34
Chemed
CHE
$6.76B
$80.8M 0.72%
170,214
+69,210
+69% +$33.2M
FDS icon
35
Factset
FDS
$9.46B
$78.1M 0.69%
232,571
+7,687
+3% +$2.52M
COO icon
36
Cooper Companies
COO
$13.7B
$76.8M 0.68%
775,204
+33,452
+5% +$3.28M
ES icon
37
Eversource Energy
ES
$28.1B
$76.5M 0.68%
953,504
-29,862
-3% -$2.51M
CSCO icon
38
Cisco
CSCO
$452B
$76M 0.68%
1,434,764
+53,741
+4% +$2.83M
FLO icon
39
Flowers Foods
FLO
$1.62B
$72.9M 0.65%
3,012,425
+181,396
+6% +$4.41M
MDT icon
40
Medtronic
MDT
$108B
$72.3M 0.64%
582,523
+22,226
+4% +$2.79M
CRI icon
41
Carter's
CRI
$1.43B
$71.3M 0.63%
690,907
+22,217
+3% +$2.26M
AKAM icon
42
Akamai
AKAM
$16.4B
$69.3M 0.62%
594,031
+30,968
+5% +$3.45M
AXP icon
43
American Express
AXP
$229B
$67.3M 0.6%
407,240
-3,401
-0.8% -$533K
BLD
44
DELISTED
TopBuild
BLD
$66.1M 0.59%
334,455
+3,264
+1% +$676K
MRK icon
45
Merck
MRK
$323B
$65.1M 0.58%
837,295
+13,977
+2% +$1.04M
CHH icon
46
Choice Hotels
CHH
$5.15B
$64.7M 0.58%
544,480
+150,861
+38% +$17.5M
DE icon
47
Deere & Co
DE
$169B
$63.7M 0.57%
180,538
-635
-0.4% -$232K
COR
48
DELISTED
Coresite Realty Corporation
COR
$62.8M 0.56%
466,398
+51,426
+12% +$6.42M
DG icon
49
Dollar General
DG
$27.2B
$62.6M 0.56%
289,199
+14,694
+5% +$3.09M
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$3.99T
$62M 0.55%
508,040
-740
-0.1% -$86.4K

Similar funds

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.